Show source-provided references
1. Present status and future directions: Microbiology of endodontic infections
10.1111/iej.13677 ↗2. Biofilms and apical periodontitis: Study of prevalence and association with clinical and histopathologic findings
10.1016/j.joen.2010.04.007 ↗8. In vivo antimicrobial effects of endodontic treatment procedures as assessed by molecular microbiologic techniques
10.1016/j.joen.2010.11.003 ↗10. Effect of chlorhexidine digluconate on different cell types: A molecular and ultrastructural investigation
10.1016/j.tiv.2007.09.012 ↗13. Regenerative endodontic procedures for the treatment of necrotic mature teeth with apical periodontitis: A systematic review and meta-analysis of randomized controlled trials
10.1016/j.joen.2021.03.015 ↗14. American Association of Endodontists (AAE) (2022, November 05). Clinical Considerations for a Regenerative Procedure. Available online: https://f3f142zs0k2w1kg84k5p9i1o-wpengine.netdna-ssl.com/specialty/wp-content/uploads/sites/2/2021/08/ClinicalConsiderationsApprovedByREC062921.pdf.
15. Nonsurgical healing of large periradicular lesions using a triple antibiotic paste: A case series
10.4103/0976-237X.62519 ↗18. Vine tea (Ampelopsis grossedentata): A review of chemical composition, functional properties, and potential food applications
10.1016/j.jff.2020.104317 ↗19. Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway
10.1111/fcp.12225 ↗20. Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia
10.1016/j.intimp.2016.12.018 ↗22. Rutin inhibits mono and multi-species biofilm formation by foodborne drug resistant Escherichia coli and Staphylococcus aureus
10.1016/j.foodcont.2017.03.004 ↗26. Synthesis and characterization of poly(N-vinylcaprolactam)-based spray-dried microparticles exhibiting temperature and pH-sensitive properties for controlled release of ketoprofen
10.1080/03639045.2017.1321660 ↗28. Guar-based injectable thermoresponsive hydrogel as a scaffold for bone cell growth and controlled drug delivery
10.1021/acsomega.8b01765 ↗31. CLSI—Clinical and Laboratory Standards Institute (2018). Performance Standards for Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute. [28th ed.].
35. New noninvasive model to study the effectiveness of dentin disinfection by using confocal laser scanning microscopy
10.1016/j.joen.2011.06.018 ↗36. Cytocompatibility and synergy of EGCG and cationic peptides against bacteria related to endodontic infections, in planktonic and biofilm conditions
10.1007/s12602-021-09830-3 ↗37. Xiao, X.N., Wang, F., Yuan, Y.T., Liu, J., Liu, Y.Z., and Yi, X. (2019). Antibacterial activity and mode of action of dihydromyricetin from Ampelopsis grossedentata leaves against food-borne Bacteria. Molecules, 24.
10.3390/molecules24152831 ↗38. Inhibitory effect of 2R,3R-dihydromyricetin on biofilm formation by Staphylococcus aureus
10.1089/fpd.2017.2405 ↗39. Antibacterial activity of flavonoids and their structure-activity relationship: An update review
10.1002/ptr.6208 ↗40. Shevelev, A.B., La Porta, N., Isakova, E.P., Martens, S., Biryukova, Y.K., Belous, A.S., Sivokhin, D.A., Trubnikova, E.V., Zylkova, M.V., and Belyakova, A.V. (2020). In vivo antimicrobial and wound-healing activity of resveratrol, dihydroquercetin, and dihydromyricetin against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Pathogens, 9.
10.3390/pathogens9040296 ↗42. Effect of flavonoids on antimicrobial activity of microorganisms present in dental plaque
43. Effect of the natural flavonoids myricetin and dihydromyricetin on the wound healing process in vitro
10.32725/jab.2021.017 ↗44. Ferreira, M., Costa, D., and Sousa, Â. (2022). Flavonoids-based delivery systems towards cancer therapies. Bioengineering, 9.
10.3390/bioengineering9050197 ↗45. Controlled release from thermo-sensitive PNVCL-co-MAA electrospun nanofibers: The effects of hydrophilicity/hydrophobicity of a drug
10.1016/j.msec.2016.05.083 ↗46. Solanki, S.S., Sarkar, B., and Dhanwani, R.K. (2012). Microemulsion drug delivery system: For bioavailability enhancement of ampelopsin. ISRN Pharm., 108164.
10.5402/2012/108164 ↗47. Fallon, M., Halligan, S., Pezzoli, R., Geever, L., and Higginbotham, C. (2019). Synthesis and characterisation of novel temperature and pH sensitive physically cross-linked poly (N-vinylcaprolactam-co-itaconic Acid) hydrogels for drug delivery. Gels, 5.
10.3390/gels5030041 ↗49. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
10.1093/femsre/fux010 ↗53. Polymicrobial interactions induce multidrug tolerance in Staphylococcus aureus through energy depletion
10.3389/fmicb.2019.02803 ↗54. Dual responsive pectin hydrogels and their silver nanocomposites: Swelling studies, controlled drug delivery and antimicrobial applications
10.5012/bkcs.2014.35.8.2391 ↗55. Development of graft copolymer of carboxymethylcellulose and N-vinylcaprolactam towards strong antioxidant and antibacterial polymeric materials
10.1016/j.ijbiomac.2018.02.030 ↗56. Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam)
10.1016/j.biomaterials.2004.09.008 ↗57. Poly(vinylcaprolactam)-based biodegradable multiresponsive microgels for drug delivery
10.1021/bm401131w ↗59. Gonzalez-Urias, A., Licea-Claverie, A., Sañudo-Barajas, J.A., and González-Ayón, M.A. (2022). NVCL-Based Hydrogels and Composites for Biomedical Applications: Progress in the Last Ten Years. Int. J. Mol. Sci., 23.
10.3390/ijms23094722 ↗